Key Developments: Neogen Corp (NEOG.O)
55.35USD
17 May 2013
$1.35 (+2.50%)
$54.00
$54.18
$55.42
$54.07
77,451
76,567
$55.42
$37.26
Latest Key Developments (Source: Significant Developments)
Neogen Corp Acquires Assets Of Scidera Genomics, LLC
Neogen Corp announced that it has acquired the assets of Scidera Genomics, LLC, an animal genomics business based in Davis, California. The acquisition, effective as of January 1, will be reported as a part of Neogen's animal safety segment. Terms of the acquisition were not disclosed. Neogen plans to retain Scidera's current employees and continue to operate from the Company's facilities in Davis. Full Article
Neogen Corp Acquires Macleod Pharmaceuticals
Neogen Corp announced that it has acquired the stock of Macleod Pharmaceuticals, an animal health company headquartered in Fort Collins, Colorado. The Macleod business will be reported as a part of Neogen's animal safety group. Terms of the transaction were not disclosed. Full Article
Neogen Corporation Launches NeoSEEK System
Neogen Corporation announced the development of a pathogen detection and identification technology that provides next day, DNA-specific test results for seven pathogenic E. coli strains. The technology could be adapted to target almost any bacterium of concern in almost any food sample type. Neogen's new NeoSEEK pathogen DNA detection method for E. coli strains is the first food safety laboratory technology developed through the close collaboration of Neogen's food safety research group and the Company's GeneSeek research team. Full Article
Neogen Corporation Acquires VeroMara From GlycoMar Ltd.
Neogen Corporation announced that it has acquired the assets of the VeroMara seafood testing laboratory from its parent company, GlycoMar Ltd. Based in Oban, Scotland, VeroMara offers testing services to the shellfish and salmon aquaculture industries. VeroMara's services include testing for shellfish toxins, general foodborne pathogens, including E. coli, noroviruses, and salmon husbandry. Terms of the acquisition were not disclosed. Full Article
Neogen Corporation's BetaStar Plus Dairy Antibiotic Test Approved By FDA/NCIMS
Neogen Corporation announced that it has received approval from the FDA and National Conference on Interstate Milk Shipments (NCIMS) for its quick and easy BetaStar Plus assay, developed for use in the United States to detect dairy antibiotic residues, including ceftiofur, in milk. This approval allows milk producers and processors in the U.S. to use Neogen's new test to comply with FDA regulations that require the mandatory testing of raw milk tankers for dairy antibiotic residues, under Appendix N of the Pasteurized Milk Ordinance (PMO). Neogen's newly approved BetaStar Plus test detects dairy antibiotic residues in the beta-lactam group (penicillin, ampicillin, amoxicillin, cephapirin, ceftiofur and cloxacillin) at or below U.S. FDA regulatory levels. BetaStar is an extremely simple dipstick test that requires only minimal training and equipment to produce consistently accurate results. Full Article
Earnings vs. 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
